IP Library Granted Patent US 10,233,427
Granted Patent B2
US 10,233,427 · App. 14/940,363 · Granted Mar 19, 2019

Fiber scaffolds for use in esophageal prostheses

Inventor: Jed Johnson (London, OH)
Assignee: NANOFIBER SOLUTIONS, LLC
C12N5/0697A61L27/14A61L27/18A61L27/3612A61L27/3679A61L27/3691A61L27/38A61L27/3882A61L27/507C12N5/0068A61L2430/22C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,233,427
App. No.
14/940,363
Granted
Mar 19, 2019
Kind
B2
Abstract

The development and construction of implantable artificial organs, and a process for manufacturing three-dimensional polymer microscale and nanoscale structures for use as scaffolds in the growth of biological structures such as hollow organs, luminal structures, or other structures within the body are disclosed.

Claims (21)

1. An implantable artificial organ scaffold comprising:

one or more electrospun fibers, each fiber comprising a polymer and a radio opaque compound;

wherein the one or more electrospun fibers are formed into a layer having a fiber orientation selected from the group consisting of substantially parallel, randomly oriented, and a combination thereof, wherein the layer has a fiber spacing from about 2 μm to about 50 μm; and

wherein the implantable artificial organ scaffold is formed into a luminal structure having an interior surface that is smooth on the microscale.

2. The implantable artificial organ scaffold of claim 1 , further comprising a plurality of biological cells seeded on the scaffold, the biological cells selected from the group consisting of cord blood cells, embryonic stem cells, induced pluripotent cells, mesenchymal cells, placental cells, bone marrow derived cells, hematopoietic cells, epithelial cells, endothelial cells, fibroblast cells, chondrocyte cells, and combinations thereof.

3. The implantable artificial organ scaffold of claim 1 , wherein the luminal structure has a shape of a biological organ selected from the group consisting of an esophagus, a small intestine, a large intestine, a duodenum, and a jejunum.

4. The implantable artificial organ scaffold of claim 1 , further comprising a supportive material.

5. The implantable artificial organ scaffold of claim 4 , wherein the supportive material comprises simulated cartilage.

6. A method of fabricating an implantable artificial organ scaffold, the method comprising:

depositing, by electrospinning, a layer of one or more fibers comprising a polymer and a radio opaque compound onto a preform, wherein the layer has a fiber orientation selected from the group consisting of substantially parallel, randomly oriented, and a combination thereof, wherein the layer has a fiber spacing from about 2 μm to about 50 μm and wherein the layer is formed into a luminal structure having an interior surface that is smooth on the microscale; and

removing the layer from the preform.

7. The method of claim 6 , wherein the preform has a shape based on a biological organ selected from the group consisting of an esophagus, a small intestine, a large intestine, a duodenum, and a jejunum.

8. The method of claim 6 , further comprising seeding a plurality of biological cells onto the layer.

9. The method of claim 8 , wherein the biological cells are selected from the group consisting of cord blood cells, embryonic stem cells, induced pluripotent cells, mesenchymal cells, placental cells, bone marrow derived cells, hematopoietic cells, epithelial cells, endothelial cells, fibroblast cells, chondrocyte cells, and combinations thereof.

10. The method of claim 6 , further comprising subjecting the layer to a mechanical stress.

11. The method of claim 6 , wherein the electrospinning comprises:

extruding a polymer solution from a fiberization tip;

creating an electronic field proximate to the fiberization tip; and

providing a ground or opposite polarity to the preform.

12. The method of claim 11 , wherein the polymer solution comprises a polymer and one or more radio opaque compounds.

13. The method of claim 11 , wherein the polymer solution comprises a polymer and one or more of fluorescence compounds, anti-bacterial compounds, growth hormones, conductive compounds, ceramic compounds, and metallic compounds.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2022
From: NANOFIBER SOLUTIONS, LLC
To: NFS IP HOLDINGS, LLC
Reel/Frame 061882/0663 →
CHANGE OF NAME Recorded Mar 21, 2019
From: NANOFIBER SOLUTIONS, INC.
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 048680/0973 →
CHANGE OF NAME Recorded Jan 22, 2019
From: NANOFIBER SOLUTIONS, INC
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 048105/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2015
From: JOHNSON, JED
To: NANOFIBER SOLUTIONS, INC.
Reel/Frame 037293/0340 →
Continuity (5)
Continuation 13385612 · Feb 9, 2012
Provisional Application 61466039 · Mar 22, 2011
Provisional Application 61562090 · Nov 21, 2011
Provisional Application 61585869 · Jan 12, 2012
Related Publication 20160325019A1 · Nov 10, 2016
Cited By (5)
US 12,201,749 US 12,246,114 US 12,263,269 US 12,491,061 US 12,564,658